Functionally and mechanistically, circ-ERBIN promoted the progression of CRC through circ-ERBIN/miR-125a-5p/miR-138-5p/4EBP-1 axis activated cap-independent HIF-1α translation, suggesting circ-ERBIN as a potentially promising therapeutic target for CRC. The gene discussed is ERBIN; the disease is colorectal carcinoma.